| Ms Michelle Lynn Maki, APNP | |
|
1821 S. Webster Avenue, Green Bay, WI 54301-2253 | |
| (920) 496-4700 | |
| Not Available |
| Full Name | Ms Michelle Lynn Maki |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 14 Years |
| Location | 1821 S. Webster Avenue, Green Bay, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053631564 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Vincent Hospital | Green bay, WI | Hospital |
| Hshs St Clare Memorial Hospital | Oconto falls, WI | Hospital |
| St Mary's Hospital Medical Center | Green bay, WI | Hospital |
| Door County Medical Center | Sturgeon bay, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Vincent Hospital-hospital Sisters-third Order Of St Francis | 5799694675 | 562 |
News Archive
Biogazelle NV, a CRO specialized in RNA analytics, has announced the initiation of large-scale testing of patient samples for SARS-CoV-2. Biogazelle is providing one of the multiple testing sites in a government-led consortium of pharma, biotech, IT and academia, alongside Janssen Pharmaceutica (J&J), GSK, UCB, UgenTec, MIPS and ThermoFisher.
A global analysis of brain proteins over a 10-week period in a mouse model of Huntington Disease has revealed some new insights into this complex neurodegenerative disorder.
A report from investigators at the Massachusetts General Hospital (MGH) Cancer Center has defined the role of a recently identified gene abnormality in a deadly form of lung cancer. Tumors driven by rearrangements in the ROS1 gene represent 1 to 2 percent of non-small-cell lung cancers (NSCLC), the leading cause of cancer death in the U.S.
Researchers at the University of Surrey have found that non-invasive skin swab samples may be enough to detect COVID-19.
› Verified 1 days ago
| Entity Name | Prevea Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306869276 PECOS PAC ID: 0042123150 Enrollment ID: O20031106000034 |
News Archive
Biogazelle NV, a CRO specialized in RNA analytics, has announced the initiation of large-scale testing of patient samples for SARS-CoV-2. Biogazelle is providing one of the multiple testing sites in a government-led consortium of pharma, biotech, IT and academia, alongside Janssen Pharmaceutica (J&J), GSK, UCB, UgenTec, MIPS and ThermoFisher.
A global analysis of brain proteins over a 10-week period in a mouse model of Huntington Disease has revealed some new insights into this complex neurodegenerative disorder.
A report from investigators at the Massachusetts General Hospital (MGH) Cancer Center has defined the role of a recently identified gene abnormality in a deadly form of lung cancer. Tumors driven by rearrangements in the ROS1 gene represent 1 to 2 percent of non-small-cell lung cancers (NSCLC), the leading cause of cancer death in the U.S.
Researchers at the University of Surrey have found that non-invasive skin swab samples may be enough to detect COVID-19.
› Verified 1 days ago
| Entity Name | St. Nicholas Hospital-sisters Of The Third Order Of St Francis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275799413 PECOS PAC ID: 8325931652 Enrollment ID: O20040202001172 |
News Archive
Biogazelle NV, a CRO specialized in RNA analytics, has announced the initiation of large-scale testing of patient samples for SARS-CoV-2. Biogazelle is providing one of the multiple testing sites in a government-led consortium of pharma, biotech, IT and academia, alongside Janssen Pharmaceutica (J&J), GSK, UCB, UgenTec, MIPS and ThermoFisher.
A global analysis of brain proteins over a 10-week period in a mouse model of Huntington Disease has revealed some new insights into this complex neurodegenerative disorder.
A report from investigators at the Massachusetts General Hospital (MGH) Cancer Center has defined the role of a recently identified gene abnormality in a deadly form of lung cancer. Tumors driven by rearrangements in the ROS1 gene represent 1 to 2 percent of non-small-cell lung cancers (NSCLC), the leading cause of cancer death in the U.S.
Researchers at the University of Surrey have found that non-invasive skin swab samples may be enough to detect COVID-19.
› Verified 1 days ago
| Entity Name | St Clare Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851477913 PECOS PAC ID: 0446211395 Enrollment ID: O20041023000037 |
News Archive
Biogazelle NV, a CRO specialized in RNA analytics, has announced the initiation of large-scale testing of patient samples for SARS-CoV-2. Biogazelle is providing one of the multiple testing sites in a government-led consortium of pharma, biotech, IT and academia, alongside Janssen Pharmaceutica (J&J), GSK, UCB, UgenTec, MIPS and ThermoFisher.
A global analysis of brain proteins over a 10-week period in a mouse model of Huntington Disease has revealed some new insights into this complex neurodegenerative disorder.
A report from investigators at the Massachusetts General Hospital (MGH) Cancer Center has defined the role of a recently identified gene abnormality in a deadly form of lung cancer. Tumors driven by rearrangements in the ROS1 gene represent 1 to 2 percent of non-small-cell lung cancers (NSCLC), the leading cause of cancer death in the U.S.
Researchers at the University of Surrey have found that non-invasive skin swab samples may be enough to detect COVID-19.
› Verified 1 days ago
| Entity Name | St Vincent Hospital-hospital Sisters-third Order Of St Francis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285613638 PECOS PAC ID: 5799694675 Enrollment ID: O20080620000423 |
News Archive
Biogazelle NV, a CRO specialized in RNA analytics, has announced the initiation of large-scale testing of patient samples for SARS-CoV-2. Biogazelle is providing one of the multiple testing sites in a government-led consortium of pharma, biotech, IT and academia, alongside Janssen Pharmaceutica (J&J), GSK, UCB, UgenTec, MIPS and ThermoFisher.
A global analysis of brain proteins over a 10-week period in a mouse model of Huntington Disease has revealed some new insights into this complex neurodegenerative disorder.
A report from investigators at the Massachusetts General Hospital (MGH) Cancer Center has defined the role of a recently identified gene abnormality in a deadly form of lung cancer. Tumors driven by rearrangements in the ROS1 gene represent 1 to 2 percent of non-small-cell lung cancers (NSCLC), the leading cause of cancer death in the U.S.
Researchers at the University of Surrey have found that non-invasive skin swab samples may be enough to detect COVID-19.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Michelle Lynn Maki, APNP Po Box 19070, Green Bay, WI 54307-9070 Ph: (920) 496-4700 | Ms Michelle Lynn Maki, APNP 1821 S. Webster Avenue, Green Bay, WI 54301-2253 Ph: (920) 496-4700 |
News Archive
Biogazelle NV, a CRO specialized in RNA analytics, has announced the initiation of large-scale testing of patient samples for SARS-CoV-2. Biogazelle is providing one of the multiple testing sites in a government-led consortium of pharma, biotech, IT and academia, alongside Janssen Pharmaceutica (J&J), GSK, UCB, UgenTec, MIPS and ThermoFisher.
A global analysis of brain proteins over a 10-week period in a mouse model of Huntington Disease has revealed some new insights into this complex neurodegenerative disorder.
A report from investigators at the Massachusetts General Hospital (MGH) Cancer Center has defined the role of a recently identified gene abnormality in a deadly form of lung cancer. Tumors driven by rearrangements in the ROS1 gene represent 1 to 2 percent of non-small-cell lung cancers (NSCLC), the leading cause of cancer death in the U.S.
Researchers at the University of Surrey have found that non-invasive skin swab samples may be enough to detect COVID-19.
› Verified 1 days ago
Elizabeth Ostoja, MSN, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1976 Lime Kiln Rd, Green Bay, WI 54311 Phone: 920-445-7377 Fax: 920-592-9479 | |
Tammy Ann Motquin, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 744 S Webster Ave, Green Bay, WI 54301 Phone: 920-445-7226 | |
Mary C Fox, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3237 Voyager Dr, Green Bay, WI 54311 Phone: 920-468-8288 | |
Mrs. Kristen Kay Lampe, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 720 S Van Buren St, Suite 201, Green Bay, WI 54301 Phone: 920-433-7488 | |
Nicole L Lowe, APNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2253 W Mason St, Green Bay, WI 54303 Phone: 920-327-7300 Fax: 920-327-7348 | |
Mr. Cristian A Vasiliev, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 923 Eliza St, Green Bay, WI 54301 Phone: 920-965-4800 | |
Linda Susan Haen, FNPC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2641 Development Drive, Green Bay, WI 54311 Phone: 920-338-6868 Fax: 920-338-6869 |